caffeine has been researched along with Weight Gain in 50 studies
Weight Gain: Increase in BODY WEIGHT over existing weight.
| Excerpt | Relevance | Reference |
|---|---|---|
| "This retrospective study reviewed weight gain, time to reach full feeds and time to cease caffeine in PBs previously enrolled in the RCT." | 9.19 | CeasIng Cpap At standarD criteriA (CICADA): impact on weight gain, time to full feeds and caffeine use. ( Abdel-Latif, ME; Broom, M; Shadbolt, B; Stewart, A; Todd, DA; Wright, A; Ying, L, 2014) |
| "Methylxanthines reduce the frequency of apnea of prematurity and the need for mechanical ventilation during the first seven days of therapy." | 9.12 | Caffeine therapy for apnea of prematurity. ( Barrington, KJ; Davis, P; Doyle, LW; Ohlsson, A; Roberts, RS; Schmidt, B; Solimano, A; Tin, W, 2006) |
| " Main outcome measures were (1) self-reported abstinence with validation by carbon monoxide in expired air and serum cotinine and (2) weight gain." | 9.08 | The effect of ephedrine plus caffeine on smoking cessation and postcessation weight gain. ( Iversen, E; Jakobsen, HB; Jørgensen, S; Mikkelsen, KL; Nørregaard, J; Søeberg, B; Sørensen, T; Tønnesen, P, 1996) |
| "To study the association between maternal caffeine intake during pregnancy and the child's weight gain and overweight risk up to 8 years." | 7.88 | Maternal caffeine intake during pregnancy and childhood growth and overweight: results from a large Norwegian prospective observational cohort study. ( Alexander, J; Bacelis, J; Botton, J; Brantsæter, AL; Elfvin, A; Haugen, M; Jacobsson, B; Meltzer, HM; Papadopoulou, E; Sengpiel, V, 2018) |
| "The associations of maternal caffeine intake during pregnancy with offspring growth patterns and body fat and insulin levels at school age were examined." | 7.83 | Maternal caffeine intake during pregnancy, early growth, and body fat distribution at school age. ( Franco, OH; Gaillard, R; Gishti, O; Hofman, A; Jaddoe, VW; Voerman, E, 2016) |
| "This study was designed to determine (1) whether chronic amitriptyline administration was effective in alleviating symptoms of neuropathic pain in a rat model of spinal nerve injury, and (2) whether the effect of amitriptyline involved manipulation of endogenous adenosine, by determining the effect of caffeine, a non-selective adenosine A(1) and A(2) receptor antagonist, on its actions." | 7.71 | Chronic administration of amitriptyline and caffeine in a rat model of neuropathic pain: multiple interactions. ( Allen, GV; Chase, T; Esser, MJ; Sawynok, J, 2001) |
| "Caffeine or NaCl 0." | 6.90 | Caffeine administered to pregnant sows improves piglet vitality, gas exchange and body weight gain. ( Ballesteros-Rodea, G; Bonilla-Jaime, H; González-Hernández, M; González-Lozano, M; Orozco-Gregorio, H; Roldán-Santiago, P; Sánchez-Salcedo, JA, 2019) |
| "This retrospective study reviewed weight gain, time to reach full feeds and time to cease caffeine in PBs previously enrolled in the RCT." | 5.19 | CeasIng Cpap At standarD criteriA (CICADA): impact on weight gain, time to full feeds and caffeine use. ( Abdel-Latif, ME; Broom, M; Shadbolt, B; Stewart, A; Todd, DA; Wright, A; Ying, L, 2014) |
| " The objective of this study is to assess if removal of caffeine from SSBs allows co-removal of sucrose (energy) without affecting flavour of SSBs, and if removal of caffeine could potentially affect population weight gain." | 5.15 | The influence of caffeine on energy content of sugar-sweetened beverages: 'the caffeine-calorie effect'. ( Keast, RS; Riddell, LJ; Sacks, G; Sayompark, D; Swinburn, BA, 2011) |
| "Methylxanthines reduce the frequency of apnea of prematurity and the need for mechanical ventilation during the first seven days of therapy." | 5.12 | Caffeine therapy for apnea of prematurity. ( Barrington, KJ; Davis, P; Doyle, LW; Ohlsson, A; Roberts, RS; Schmidt, B; Solimano, A; Tin, W, 2006) |
| " Main outcome measures were (1) self-reported abstinence with validation by carbon monoxide in expired air and serum cotinine and (2) weight gain." | 5.08 | The effect of ephedrine plus caffeine on smoking cessation and postcessation weight gain. ( Iversen, E; Jakobsen, HB; Jørgensen, S; Mikkelsen, KL; Nørregaard, J; Søeberg, B; Sørensen, T; Tønnesen, P, 1996) |
| "To study the association between maternal caffeine intake during pregnancy and the child's weight gain and overweight risk up to 8 years." | 3.88 | Maternal caffeine intake during pregnancy and childhood growth and overweight: results from a large Norwegian prospective observational cohort study. ( Alexander, J; Bacelis, J; Botton, J; Brantsæter, AL; Elfvin, A; Haugen, M; Jacobsson, B; Meltzer, HM; Papadopoulou, E; Sengpiel, V, 2018) |
| " Cyproheptadine, dexamethasone, sildenafil, tramadol, caffeine and acetaminophen were detected in herbal weight gain drugs." | 3.88 | Determination of synthetic pharmaceutical adulterants in herbal weight gain supplements sold in herb shops, Tehran, Iran. ( Akhgari, M; Bahmanabadi, L; Bazmi, E; Mousavi, Z; Saberi, N, 2018) |
| "The combination of caffeine and catechins regulated the enzymatic activities, mRNA, and protein expression levels of lipid metabolism-related enzymes, resulting in suppression of body weight gain and IPAT weight in mice, potentially through activation of the AMPK signaling pathway." | 3.85 | Synergistic effects of caffeine and catechins on lipid metabolism in chronically fed mice via the AMP-activated protein kinase signaling pathway. ( Huang, Z; Lin, L; Yang, L; Zhao, Y; Zheng, G, 2017) |
| "The associations of maternal caffeine intake during pregnancy with offspring growth patterns and body fat and insulin levels at school age were examined." | 3.83 | Maternal caffeine intake during pregnancy, early growth, and body fat distribution at school age. ( Franco, OH; Gaillard, R; Gishti, O; Hofman, A; Jaddoe, VW; Voerman, E, 2016) |
| "Caffeine, a methylxanthine present in coffee, has been postulated to be responsible for an increased risk of osteoporosis in coffee drinkers; however, the data are inconsistent." | 3.79 | Favorable effect of moderate dose caffeine on the skeletal system in ovariectomized rats. ( Cegieła, U; Folwarczna, J; Kaczmarczyk-Sedlak, I; Nowińska, B; Pytlik, M; Sliwiński, L; Zych, M, 2013) |
| " CUS-exposed rats showed depressive-like behavior with reduced weight gain, reduced consumption of sucrose solution, increased immobility in the forced swimming test, and hypolocomotion in an open field." | 3.78 | Effect of long-term caffeine administration on depressive-like behavior in rats exposed to chronic unpredictable stress. ( Alova, LH; Nikolov, RP; Pechlivanova, DM; Petkov, VV; Tchekalarova, JD; Yakimova, KS, 2012) |
| "Increases in caffeine intake may lead to a small reduction in long-term weight gain." | 3.73 | Changes in caffeine intake and long-term weight change in men and women. ( Hu, FB; Lopez-Garcia, E; Manson, JE; Rajpathak, S; van Dam, RM; Willett, WC, 2006) |
| "This study was designed to determine (1) whether chronic amitriptyline administration was effective in alleviating symptoms of neuropathic pain in a rat model of spinal nerve injury, and (2) whether the effect of amitriptyline involved manipulation of endogenous adenosine, by determining the effect of caffeine, a non-selective adenosine A(1) and A(2) receptor antagonist, on its actions." | 3.71 | Chronic administration of amitriptyline and caffeine in a rat model of neuropathic pain: multiple interactions. ( Allen, GV; Chase, T; Esser, MJ; Sawynok, J, 2001) |
| "Pregnant Yorkshire gilts (n = 42) were fed caffeine (6 g/d) or served as controls from d 60 of pregnancy until d 4 postpartum to test the effect of caffeine on mammary gland development, milk yield, and feed consumption." | 3.69 | The effect of caffeine on mammary gland development and milk yield in primiparous sows. ( Hacker, RR; Li, S, 1995) |
| "The involvement of CRH and the sympatho-adrenal system in the effects of caffeine on food intake and body weight gain has been investigated in rats." | 3.69 | The effect of caffeine on food intake in rats: involvement of corticotropin-releasing factor and the sympatho-adrenal system. ( Leblanc, J; Racotta, IS; Richard, D, 1994) |
| "Caffeine or NaCl 0." | 2.90 | Caffeine administered to pregnant sows improves piglet vitality, gas exchange and body weight gain. ( Ballesteros-Rodea, G; Bonilla-Jaime, H; González-Hernández, M; González-Lozano, M; Orozco-Gregorio, H; Roldán-Santiago, P; Sánchez-Salcedo, JA, 2019) |
| "Obesity is a worldwide prevalent metabolic disorder that is associated with diabetes, among many other diseases." | 2.66 | Attenuation of Weight Gain and Prevention of Associated Pathologies by Inhibiting SSAO. ( Deng, Y; Papukashvili, D; Rcheulishvili, N, 2020) |
| "Nutrition during pregnancy has become an integral component of prenatal care." | 2.39 | Nutrition during pregnancy. ( Luke, B, 1994) |
| "To identify dosing strategies that will assure stable caffeine concentrations in preterm neonates despite changing caffeine clearance during the first 8 weeks of life." | 1.46 | Caffeine Citrate Dosing Adjustments to Assure Stable Caffeine Concentrations in Preterm Neonates. ( Datta, AN; Jost, K; Koch, G; Pfister, M; Schulzke, SM; van den Anker, J, 2017) |
| "Caffeine is a psychostimulant commonly consumed with high levels of sugar." | 1.43 | Extended exposure to sugar and/or caffeine produces distinct behavioral and neurochemical profiles in the orbitofrontal cortex of rats: Implications for neural function. ( Cornish, JL; Franklin, JL; Goodchild, AK; Haynes, PA; Homewood, J; Mirzaei, M; Wearne, TA, 2016) |
| " Chronic administration of GTD in rat fed high-fat diet reduced body weight gain, circulating triglycerides and cholesterol and improved glucose tolerance." | 1.40 | Green tea decoction improves glucose tolerance and reduces weight gain of rats fed normal and high-fat diet. ( Abaidi, H; Bado, A; Cluzeaud, F; Dhaouadi, K; Ducroc, R; Hamdaoui, MH; Le Gall, M; Nazaret, C; Snoussi, C, 2014) |
| " The present study was undertaken to evaluate the reproductive toxic effect of meclizine and caffeine combination." | 1.40 | Prenatal and developmental toxicity study of meclizine and caffeine combination in female albino Wistar rats. ( Alvin, JM; Sandeep, M, 2014) |
| "Caffeine is a definite factor of intrauterine growth retardation (IUGR)." | 1.38 | A hypothalamic-pituitary-adrenal axis-associated neuroendocrine metabolic programmed alteration in offspring rats of IUGR induced by prenatal caffeine ingestion. ( Chen, LB; Lei, YY; Liu, F; Liu, J; Liu, YS; Magdalou, J; Ping, J; Qin, J; Shen, L; Wang, H; Wu, Y; Xu, D; Zhang, C, 2012) |
| "Necrosis was not present in the rats fed ephedrine alone." | 1.32 | Mechanism of the alcohol cyclic pattern: role of catecholamines. ( Bardag-Gorce, F; French, BA; French, SW; Fu, P; Li, J, 2003) |
| "The caffeine was fed via the animals' dietary water and the dosage was 10 mg/100 g body weight per day, 3 days a week." | 1.31 | Effects of caffeine and exercise on the development of bone: a densitometric and histomorphometric study in young Wistar rats. ( Hsieh, SS; Huang, TH; Liu, SH; Yang, RS, 2002) |
| "Caffeine was added (0." | 1.29 | Long-term caffeine treatment leads to a decreased susceptibility to NMDA-induced clonic seizures in mice without changes in adenosine A1 receptor number. ( Fredholm, BB; Georgiev, V; Johansson, B, 1993) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 9 (18.00) | 18.2507 |
| 2000's | 13 (26.00) | 29.6817 |
| 2010's | 24 (48.00) | 24.3611 |
| 2020's | 4 (8.00) | 2.80 |
| Authors | Studies |
|---|---|
| Henn, M | 1 |
| Glenn, AJ | 1 |
| Willett, WC | 2 |
| Martínez-González, MA | 1 |
| Sun, Q | 1 |
| Hu, FB | 2 |
| Sánchez-Salcedo, JA | 1 |
| Orozco-Gregorio, H | 1 |
| González-Lozano, M | 1 |
| Roldán-Santiago, P | 1 |
| González-Hernández, M | 1 |
| Ballesteros-Rodea, G | 1 |
| Bonilla-Jaime, H | 1 |
| Papukashvili, D | 1 |
| Rcheulishvili, N | 1 |
| Deng, Y | 1 |
| Eltahir, HM | 1 |
| Alamri, G | 1 |
| Alamri, A | 1 |
| Aloufi, A | 1 |
| Nazmy, M | 1 |
| Elbadawy, H | 1 |
| Bahashwan, S | 1 |
| Elbadawy, HM | 1 |
| Alahmadi, YM | 1 |
| Abouzied, M | 1 |
| Jing, N | 1 |
| Liu, X | 1 |
| Jin, M | 1 |
| Yang, X | 1 |
| Hu, X | 1 |
| Li, C | 1 |
| Zhao, K | 1 |
| Jing, X | 1 |
| Huang, YW | 1 |
| Jarzembowski, J | 1 |
| Shi, Y | 1 |
| Konduri, GG | 1 |
| Teng, RJ | 1 |
| Koch, G | 1 |
| Datta, AN | 1 |
| Jost, K | 1 |
| Schulzke, SM | 1 |
| van den Anker, J | 1 |
| Pfister, M | 1 |
| Papadopoulou, E | 1 |
| Botton, J | 1 |
| Brantsæter, AL | 1 |
| Haugen, M | 1 |
| Alexander, J | 1 |
| Meltzer, HM | 1 |
| Bacelis, J | 1 |
| Elfvin, A | 1 |
| Jacobsson, B | 1 |
| Sengpiel, V | 1 |
| Saberi, N | 1 |
| Akhgari, M | 1 |
| Bahmanabadi, L | 1 |
| Bazmi, E | 1 |
| Mousavi, Z | 1 |
| Folwarczna, J | 1 |
| Pytlik, M | 1 |
| Zych, M | 1 |
| Cegieła, U | 1 |
| Kaczmarczyk-Sedlak, I | 1 |
| Nowińska, B | 1 |
| Sliwiński, L | 1 |
| Snoussi, C | 1 |
| Ducroc, R | 1 |
| Hamdaoui, MH | 1 |
| Dhaouadi, K | 1 |
| Abaidi, H | 1 |
| Cluzeaud, F | 1 |
| Nazaret, C | 1 |
| Le Gall, M | 1 |
| Bado, A | 1 |
| Broom, M | 1 |
| Ying, L | 1 |
| Wright, A | 1 |
| Stewart, A | 1 |
| Abdel-Latif, ME | 1 |
| Shadbolt, B | 1 |
| Todd, DA | 1 |
| Salahdeen, HM | 1 |
| Omoaghe, AO | 1 |
| Isehunwa, GO | 1 |
| Murtala, BA | 1 |
| Alada, AR | 1 |
| Sandeep, M | 1 |
| Alvin, JM | 1 |
| Malek, L | 1 |
| Makrides, M | 1 |
| Rocha, A | 1 |
| Bolin, AP | 1 |
| Cardoso, CA | 1 |
| Otton, R | 1 |
| Luo, H | 1 |
| Li, J | 2 |
| Cao, H | 1 |
| Tan, Y | 1 |
| Magdalou, J | 2 |
| Chen, L | 1 |
| Wang, H | 2 |
| Voerman, E | 1 |
| Jaddoe, VW | 1 |
| Gishti, O | 1 |
| Hofman, A | 1 |
| Franco, OH | 1 |
| Gaillard, R | 1 |
| Zhao, Y | 1 |
| Yang, L | 1 |
| Huang, Z | 1 |
| Lin, L | 1 |
| Zheng, G | 1 |
| Franklin, JL | 1 |
| Mirzaei, M | 1 |
| Wearne, TA | 1 |
| Homewood, J | 1 |
| Goodchild, AK | 1 |
| Haynes, PA | 1 |
| Cornish, JL | 1 |
| Lean, ME | 1 |
| Te Morenga, L | 1 |
| Berkey, CS | 1 |
| Rockett, HR | 1 |
| Colditz, GA | 1 |
| Richard, D | 2 |
| Kefi, K | 1 |
| Barbe, U | 1 |
| Poli, A | 1 |
| Bausero, P | 1 |
| Visioli, F | 1 |
| Zhang, LL | 1 |
| Zhang, JR | 1 |
| Guo, K | 1 |
| Ji, H | 1 |
| Zhang, Y | 1 |
| Jiang, SX | 1 |
| Swithers, SE | 1 |
| Martin, AA | 1 |
| Clark, KM | 1 |
| Laboy, AF | 1 |
| Davidson, TL | 1 |
| Keast, RS | 1 |
| Sayompark, D | 1 |
| Sacks, G | 1 |
| Swinburn, BA | 1 |
| Riddell, LJ | 1 |
| Celec, P | 1 |
| Pechlivanova, DM | 1 |
| Tchekalarova, JD | 1 |
| Alova, LH | 1 |
| Petkov, VV | 1 |
| Nikolov, RP | 1 |
| Yakimova, KS | 1 |
| Xu, D | 1 |
| Wu, Y | 1 |
| Liu, F | 1 |
| Liu, YS | 1 |
| Shen, L | 1 |
| Lei, YY | 1 |
| Liu, J | 1 |
| Ping, J | 1 |
| Qin, J | 1 |
| Zhang, C | 1 |
| Chen, LB | 1 |
| Moy, GA | 1 |
| McNay, EC | 1 |
| Mokelke, EA | 1 |
| Wang, M | 1 |
| Sturek, M | 1 |
| Joumaa, WH | 1 |
| Bouhlel, A | 1 |
| Léoty, C | 1 |
| French, BA | 1 |
| Fu, P | 1 |
| Bardag-Gorce, F | 1 |
| French, SW | 1 |
| Lopez-Garcia, E | 1 |
| van Dam, RM | 1 |
| Rajpathak, S | 1 |
| Manson, JE | 1 |
| Schmidt, B | 1 |
| Roberts, RS | 1 |
| Davis, P | 1 |
| Doyle, LW | 1 |
| Barrington, KJ | 1 |
| Ohlsson, A | 1 |
| Solimano, A | 1 |
| Tin, W | 1 |
| Coulter, DM | 1 |
| Stevenson, DK | 1 |
| Li, S | 1 |
| Hacker, RR | 1 |
| Luke, B | 1 |
| Racotta, IS | 1 |
| Leblanc, J | 1 |
| Georgiev, V | 1 |
| Johansson, B | 1 |
| Fredholm, BB | 1 |
| Monnin, S | 1 |
| Schiller, MR | 1 |
| Sachs, L | 1 |
| Smith, AM | 1 |
| Nørregaard, J | 1 |
| Jørgensen, S | 1 |
| Mikkelsen, KL | 1 |
| Tønnesen, P | 1 |
| Iversen, E | 1 |
| Sørensen, T | 1 |
| Søeberg, B | 1 |
| Jakobsen, HB | 1 |
| Kolasa, KM | 1 |
| Weismiller, DG | 1 |
| Colomina, MT | 2 |
| Sanchez, DJ | 2 |
| Esparza, JL | 1 |
| Domingo, JL | 2 |
| Sugiyama, K | 1 |
| He, P | 1 |
| Wada, S | 1 |
| Saeki, S | 1 |
| Sakamoto, W | 1 |
| Nishihira, J | 1 |
| Fujie, K | 1 |
| Mizuno, S | 1 |
| Ozaki, M | 1 |
| Yukawa, S | 1 |
| Albina, ML | 1 |
| Esser, MJ | 1 |
| Chase, T | 1 |
| Allen, GV | 1 |
| Sawynok, J | 1 |
| Huang, TH | 1 |
| Yang, RS | 1 |
| Hsieh, SS | 1 |
| Liu, SH | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Effect of Coffee and Tea Consumption on Adolescent Weight Control - a Randomized Clinical Trial[NCT05181176] | 63 participants (Anticipated) | Interventional | 2021-01-01 | Recruiting | |||
| A Prospective, Controlled Trial of Inhalation of Low Concentration of CO2 in Preterm Infants Not Responding to Caffeine for the Treatment of Apnea of Prematurity[NCT01911182] | Phase 2/Phase 3 | 7 participants (Actual) | Interventional | 2011-10-31 | Terminated (stopped due to Low recruitment rate) | ||
| High Versus Low Dose Caffeine as Respiratory Stimulant in Preterm Infants[NCT04144712] | Phase 1 | 80 participants (Anticipated) | Interventional | 2019-04-01 | Recruiting | ||
| Efficacy and Safety of Methylxanthines in Very Low Birthweight Infants[NCT00182312] | Phase 3 | 2,000 participants (Anticipated) | Interventional | 1999-10-31 | Completed | ||
| Long-Term Effects On Sleep Of Methylxanthine Therapy For Apnea Of Prematurity[NCT01020357] | Phase 3 | 201 participants (Actual) | Interventional | 2009-11-30 | Completed | ||
| [NCT01066728] | Phase 2/Phase 3 | 87 participants (Actual) | Interventional | 2001-08-31 | Completed | ||
| Safety of Sildenafil in Premature Infants With Severe Bronchopulmonary Dysplasia[NCT04447989] | Phase 2 | 120 participants (Anticipated) | Interventional | 2021-05-27 | Recruiting | ||
| A Randomized, Placebo-controlled Trial of Early Caffeine in Preterm Neonates[NCT03086473] | Phase 4 | 24 participants (Actual) | Interventional | 2017-02-01 | Active, not recruiting | ||
| Pharmacokinetics (PK) and Safety of Caffeine in Neonates With Hypoxic Ischemic Encephalopathy Receiving Therapeutic Hypothermia[NCT05295784] | Phase 1 | 18 participants (Anticipated) | Interventional | 2024-06-30 | Not yet recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
4 reviews available for caffeine and Weight Gain
| Article | Year |
|---|---|
Attenuation of Weight Gain and Prevention of Associated Pathologies by Inhibiting SSAO.
Topics: Adipocytes; Adolescent; Adult; Aged; Amine Oxidase (Copper-Containing); Animals; Anti-Obesity Agents | 2020 |
Sugar and Type 2 diabetes.
Topics: Beverages; Caffeine; Diabetes Mellitus, Type 2; Diet; Dietary Sugars; Energy Intake; Health Surveys; | 2016 |
Nutrition during pregnancy.
Topics: Caffeine; Cost-Benefit Analysis; Fatty Acids, Omega-3; Female; Folic Acid; Humans; Nutrition Policy; | 1994 |
Nutrition during pregnancy.
Topics: Caffeine; Constipation; Female; Humans; Lactose Intolerance; Nausea; Nutrition Assessment; Nutrition | 1997 |
5 trials available for caffeine and Weight Gain
| Article | Year |
|---|---|
Caffeine administered to pregnant sows improves piglet vitality, gas exchange and body weight gain.
Topics: Animal Feed; Animals; Animals, Newborn; Caffeine; Central Nervous System Stimulants; Diet; Female; P | 2019 |
CeasIng Cpap At standarD criteriA (CICADA): impact on weight gain, time to full feeds and caffeine use.
Topics: Apgar Score; Birth Weight; Caffeine; Continuous Positive Airway Pressure; Drug Administration Schedu | 2014 |
The influence of caffeine on energy content of sugar-sweetened beverages: 'the caffeine-calorie effect'.
Topics: Adolescent; Adult; Beverages; Caffeine; Child; Child, Preschool; Dietary Sucrose; Energy Intake; Fem | 2011 |
Caffeine therapy for apnea of prematurity.
Topics: Apnea; Bronchopulmonary Dysplasia; Caffeine; Central Nervous System Stimulants; Combined Modality Th | 2006 |
Caffeine therapy for apnea of prematurity.
Topics: Apnea; Bronchopulmonary Dysplasia; Caffeine; Central Nervous System Stimulants; Combined Modality Th | 2006 |
Caffeine therapy for apnea of prematurity.
Topics: Apnea; Bronchopulmonary Dysplasia; Caffeine; Central Nervous System Stimulants; Combined Modality Th | 2006 |
Caffeine therapy for apnea of prematurity.
Topics: Apnea; Bronchopulmonary Dysplasia; Caffeine; Central Nervous System Stimulants; Combined Modality Th | 2006 |
Caffeine therapy for apnea of prematurity.
Topics: Apnea; Bronchopulmonary Dysplasia; Caffeine; Central Nervous System Stimulants; Combined Modality Th | 2006 |
Caffeine therapy for apnea of prematurity.
Topics: Apnea; Bronchopulmonary Dysplasia; Caffeine; Central Nervous System Stimulants; Combined Modality Th | 2006 |
Caffeine therapy for apnea of prematurity.
Topics: Apnea; Bronchopulmonary Dysplasia; Caffeine; Central Nervous System Stimulants; Combined Modality Th | 2006 |
Caffeine therapy for apnea of prematurity.
Topics: Apnea; Bronchopulmonary Dysplasia; Caffeine; Central Nervous System Stimulants; Combined Modality Th | 2006 |
Caffeine therapy for apnea of prematurity.
Topics: Apnea; Bronchopulmonary Dysplasia; Caffeine; Central Nervous System Stimulants; Combined Modality Th | 2006 |
Caffeine therapy for apnea of prematurity.
Topics: Apnea; Bronchopulmonary Dysplasia; Caffeine; Central Nervous System Stimulants; Combined Modality Th | 2006 |
Caffeine therapy for apnea of prematurity.
Topics: Apnea; Bronchopulmonary Dysplasia; Caffeine; Central Nervous System Stimulants; Combined Modality Th | 2006 |
Caffeine therapy for apnea of prematurity.
Topics: Apnea; Bronchopulmonary Dysplasia; Caffeine; Central Nervous System Stimulants; Combined Modality Th | 2006 |
Caffeine therapy for apnea of prematurity.
Topics: Apnea; Bronchopulmonary Dysplasia; Caffeine; Central Nervous System Stimulants; Combined Modality Th | 2006 |
Caffeine therapy for apnea of prematurity.
Topics: Apnea; Bronchopulmonary Dysplasia; Caffeine; Central Nervous System Stimulants; Combined Modality Th | 2006 |
Caffeine therapy for apnea of prematurity.
Topics: Apnea; Bronchopulmonary Dysplasia; Caffeine; Central Nervous System Stimulants; Combined Modality Th | 2006 |
Caffeine therapy for apnea of prematurity.
Topics: Apnea; Bronchopulmonary Dysplasia; Caffeine; Central Nervous System Stimulants; Combined Modality Th | 2006 |
Caffeine therapy for apnea of prematurity.
Topics: Apnea; Bronchopulmonary Dysplasia; Caffeine; Central Nervous System Stimulants; Combined Modality Th | 2006 |
Caffeine therapy for apnea of prematurity.
Topics: Apnea; Bronchopulmonary Dysplasia; Caffeine; Central Nervous System Stimulants; Combined Modality Th | 2006 |
Caffeine therapy for apnea of prematurity.
Topics: Apnea; Bronchopulmonary Dysplasia; Caffeine; Central Nervous System Stimulants; Combined Modality Th | 2006 |
Caffeine therapy for apnea of prematurity.
Topics: Apnea; Bronchopulmonary Dysplasia; Caffeine; Central Nervous System Stimulants; Combined Modality Th | 2006 |
Caffeine therapy for apnea of prematurity.
Topics: Apnea; Bronchopulmonary Dysplasia; Caffeine; Central Nervous System Stimulants; Combined Modality Th | 2006 |
Caffeine therapy for apnea of prematurity.
Topics: Apnea; Bronchopulmonary Dysplasia; Caffeine; Central Nervous System Stimulants; Combined Modality Th | 2006 |
Caffeine therapy for apnea of prematurity.
Topics: Apnea; Bronchopulmonary Dysplasia; Caffeine; Central Nervous System Stimulants; Combined Modality Th | 2006 |
Caffeine therapy for apnea of prematurity.
Topics: Apnea; Bronchopulmonary Dysplasia; Caffeine; Central Nervous System Stimulants; Combined Modality Th | 2006 |
Caffeine therapy for apnea of prematurity.
Topics: Apnea; Bronchopulmonary Dysplasia; Caffeine; Central Nervous System Stimulants; Combined Modality Th | 2006 |
Caffeine therapy for apnea of prematurity.
Topics: Apnea; Bronchopulmonary Dysplasia; Caffeine; Central Nervous System Stimulants; Combined Modality Th | 2006 |
Caffeine therapy for apnea of prematurity.
Topics: Apnea; Bronchopulmonary Dysplasia; Caffeine; Central Nervous System Stimulants; Combined Modality Th | 2006 |
Caffeine therapy for apnea of prematurity.
Topics: Apnea; Bronchopulmonary Dysplasia; Caffeine; Central Nervous System Stimulants; Combined Modality Th | 2006 |
Caffeine therapy for apnea of prematurity.
Topics: Apnea; Bronchopulmonary Dysplasia; Caffeine; Central Nervous System Stimulants; Combined Modality Th | 2006 |
Caffeine therapy for apnea of prematurity.
Topics: Apnea; Bronchopulmonary Dysplasia; Caffeine; Central Nervous System Stimulants; Combined Modality Th | 2006 |
Caffeine therapy for apnea of prematurity.
Topics: Apnea; Bronchopulmonary Dysplasia; Caffeine; Central Nervous System Stimulants; Combined Modality Th | 2006 |
Caffeine therapy for apnea of prematurity.
Topics: Apnea; Bronchopulmonary Dysplasia; Caffeine; Central Nervous System Stimulants; Combined Modality Th | 2006 |
Caffeine therapy for apnea of prematurity.
Topics: Apnea; Bronchopulmonary Dysplasia; Caffeine; Central Nervous System Stimulants; Combined Modality Th | 2006 |
Caffeine therapy for apnea of prematurity.
Topics: Apnea; Bronchopulmonary Dysplasia; Caffeine; Central Nervous System Stimulants; Combined Modality Th | 2006 |
Caffeine therapy for apnea of prematurity.
Topics: Apnea; Bronchopulmonary Dysplasia; Caffeine; Central Nervous System Stimulants; Combined Modality Th | 2006 |
Caffeine therapy for apnea of prematurity.
Topics: Apnea; Bronchopulmonary Dysplasia; Caffeine; Central Nervous System Stimulants; Combined Modality Th | 2006 |
Caffeine therapy for apnea of prematurity.
Topics: Apnea; Bronchopulmonary Dysplasia; Caffeine; Central Nervous System Stimulants; Combined Modality Th | 2006 |
Caffeine therapy for apnea of prematurity.
Topics: Apnea; Bronchopulmonary Dysplasia; Caffeine; Central Nervous System Stimulants; Combined Modality Th | 2006 |
Caffeine therapy for apnea of prematurity.
Topics: Apnea; Bronchopulmonary Dysplasia; Caffeine; Central Nervous System Stimulants; Combined Modality Th | 2006 |
Caffeine therapy for apnea of prematurity.
Topics: Apnea; Bronchopulmonary Dysplasia; Caffeine; Central Nervous System Stimulants; Combined Modality Th | 2006 |
Caffeine therapy for apnea of prematurity.
Topics: Apnea; Bronchopulmonary Dysplasia; Caffeine; Central Nervous System Stimulants; Combined Modality Th | 2006 |
Caffeine therapy for apnea of prematurity.
Topics: Apnea; Bronchopulmonary Dysplasia; Caffeine; Central Nervous System Stimulants; Combined Modality Th | 2006 |
Caffeine therapy for apnea of prematurity.
Topics: Apnea; Bronchopulmonary Dysplasia; Caffeine; Central Nervous System Stimulants; Combined Modality Th | 2006 |
Caffeine therapy for apnea of prematurity.
Topics: Apnea; Bronchopulmonary Dysplasia; Caffeine; Central Nervous System Stimulants; Combined Modality Th | 2006 |
Caffeine therapy for apnea of prematurity.
Topics: Apnea; Bronchopulmonary Dysplasia; Caffeine; Central Nervous System Stimulants; Combined Modality Th | 2006 |
Caffeine therapy for apnea of prematurity.
Topics: Apnea; Bronchopulmonary Dysplasia; Caffeine; Central Nervous System Stimulants; Combined Modality Th | 2006 |
Caffeine therapy for apnea of prematurity.
Topics: Apnea; Bronchopulmonary Dysplasia; Caffeine; Central Nervous System Stimulants; Combined Modality Th | 2006 |
Caffeine therapy for apnea of prematurity.
Topics: Apnea; Bronchopulmonary Dysplasia; Caffeine; Central Nervous System Stimulants; Combined Modality Th | 2006 |
Caffeine therapy for apnea of prematurity.
Topics: Apnea; Bronchopulmonary Dysplasia; Caffeine; Central Nervous System Stimulants; Combined Modality Th | 2006 |
Caffeine therapy for apnea of prematurity.
Topics: Apnea; Bronchopulmonary Dysplasia; Caffeine; Central Nervous System Stimulants; Combined Modality Th | 2006 |
Caffeine therapy for apnea of prematurity.
Topics: Apnea; Bronchopulmonary Dysplasia; Caffeine; Central Nervous System Stimulants; Combined Modality Th | 2006 |
Caffeine therapy for apnea of prematurity.
Topics: Apnea; Bronchopulmonary Dysplasia; Caffeine; Central Nervous System Stimulants; Combined Modality Th | 2006 |
Caffeine therapy for apnea of prematurity.
Topics: Apnea; Bronchopulmonary Dysplasia; Caffeine; Central Nervous System Stimulants; Combined Modality Th | 2006 |
Caffeine therapy for apnea of prematurity.
Topics: Apnea; Bronchopulmonary Dysplasia; Caffeine; Central Nervous System Stimulants; Combined Modality Th | 2006 |
Caffeine therapy for apnea of prematurity.
Topics: Apnea; Bronchopulmonary Dysplasia; Caffeine; Central Nervous System Stimulants; Combined Modality Th | 2006 |
Caffeine therapy for apnea of prematurity.
Topics: Apnea; Bronchopulmonary Dysplasia; Caffeine; Central Nervous System Stimulants; Combined Modality Th | 2006 |
Caffeine therapy for apnea of prematurity.
Topics: Apnea; Bronchopulmonary Dysplasia; Caffeine; Central Nervous System Stimulants; Combined Modality Th | 2006 |
Caffeine therapy for apnea of prematurity.
Topics: Apnea; Bronchopulmonary Dysplasia; Caffeine; Central Nervous System Stimulants; Combined Modality Th | 2006 |
Caffeine therapy for apnea of prematurity.
Topics: Apnea; Bronchopulmonary Dysplasia; Caffeine; Central Nervous System Stimulants; Combined Modality Th | 2006 |
Caffeine therapy for apnea of prematurity.
Topics: Apnea; Bronchopulmonary Dysplasia; Caffeine; Central Nervous System Stimulants; Combined Modality Th | 2006 |
Caffeine therapy for apnea of prematurity.
Topics: Apnea; Bronchopulmonary Dysplasia; Caffeine; Central Nervous System Stimulants; Combined Modality Th | 2006 |
Caffeine therapy for apnea of prematurity.
Topics: Apnea; Bronchopulmonary Dysplasia; Caffeine; Central Nervous System Stimulants; Combined Modality Th | 2006 |
Caffeine therapy for apnea of prematurity.
Topics: Apnea; Bronchopulmonary Dysplasia; Caffeine; Central Nervous System Stimulants; Combined Modality Th | 2006 |
Caffeine therapy for apnea of prematurity.
Topics: Apnea; Bronchopulmonary Dysplasia; Caffeine; Central Nervous System Stimulants; Combined Modality Th | 2006 |
The effect of ephedrine plus caffeine on smoking cessation and postcessation weight gain.
Topics: Adult; Appetite Depressants; Blood Glucose; Breath Tests; Caffeine; Carbon Monoxide; Central Nervous | 1996 |
41 other studies available for caffeine and Weight Gain
| Article | Year |
|---|---|
Changes in Coffee Intake, Added Sugar and Long-Term Weight Gain - Results from Three Large Prospective US Cohort Studies.
Topics: Caffeine; Coffee; Cohort Studies; Follow-Up Studies; Humans; Prospective Studies; Risk Factors; Suga | 2023 |
The metabolic disorders associated with chronic consumption of soft and energy drinks in rats.
Topics: Animals; Blood Glucose; Caffeine; Carbonated Beverages; Cardiovascular Diseases; Energy Drinks; Kidn | 2020 |
Fubrick tea attenuates high-fat diet induced fat deposition and metabolic disorder by regulating gut microbiota and caffeine metabolism.
Topics: Animals; Anti-Obesity Agents; Caffeine; Diet, High-Fat; Dietary Supplements; Disease Models, Animal; | 2020 |
Caffeine ameliorates hyperoxia-induced lung injury by protecting GCH1 function in neonatal rat pups.
Topics: Animals; Animals, Newborn; Caffeine; Cyclic AMP; Female; GTP Cyclohydrolase; Hyperoxia; Lung Injury; | 2017 |
Caffeine Citrate Dosing Adjustments to Assure Stable Caffeine Concentrations in Preterm Neonates.
Topics: Apnea; Birth Weight; Caffeine; Central Nervous System Stimulants; Citrates; Dose-Response Relationsh | 2017 |
Maternal caffeine intake during pregnancy and childhood growth and overweight: results from a large Norwegian prospective observational cohort study.
Topics: Caffeine; Child; Child Development; Child, Preschool; Cohort Studies; Diet Records; Eating; Female; | 2018 |
Determination of synthetic pharmaceutical adulterants in herbal weight gain supplements sold in herb shops, Tehran, Iran.
Topics: Acetaminophen; Caffeine; Cyproheptadine; Dexamethasone; Dietary Supplements; Drug Contamination; Hum | 2018 |
Favorable effect of moderate dose caffeine on the skeletal system in ovariectomized rats.
Topics: Animals; Bone Density; Caffeine; Calcification, Physiologic; Calcium; Cholesterol; Dose-Response Rel | 2013 |
Green tea decoction improves glucose tolerance and reduces weight gain of rats fed normal and high-fat diet.
Topics: Administration, Oral; Animals; Caffeine; Catechin; Diet, High-Fat; Glucose; Glucose Tolerance Test; | 2014 |
Effects of chronic administration of ethanolic extract of kolanut (Cola nitida) and caffeine on vascular function.
Topics: Acetylcholine; Animals; Aorta; Atropine; Blood Pressure; Caffeine; Cola; Dose-Response Relationship, | 2014 |
Prenatal and developmental toxicity study of meclizine and caffeine combination in female albino Wistar rats.
Topics: Abnormalities, Drug-Induced; Administration, Oral; Animals; Body Weight; Caffeine; Dose-Response Rel | 2014 |
2.8 Nutrition in pregnancy and lactation.
Topics: Alcohol Drinking; Body Mass Index; Breast Feeding; Caffeine; Calcium, Dietary; Dairy Products; Diet; | 2015 |
Green tea extract activates AMPK and ameliorates white adipose tissue metabolic dysfunction induced by obesity.
Topics: Adipose Tissue, White; Alanine Transaminase; AMP-Activated Protein Kinases; Animals; Antioxidants; A | 2016 |
Prenatal caffeine exposure induces a poor quality of articular cartilage in male adult offspring rats via cholesterol accumulation in cartilage.
Topics: Animals; Biological Transport; Caffeine; Cartilage, Articular; Cholesterol; Diet, High-Fat; Female; | 2015 |
Maternal caffeine intake during pregnancy, early growth, and body fat distribution at school age.
Topics: Birth Weight; Body Composition; Body Fat Distribution; Body Mass Index; Caffeine; Child; Coffee; Fem | 2016 |
Synergistic effects of caffeine and catechins on lipid metabolism in chronically fed mice via the AMP-activated protein kinase signaling pathway.
Topics: Acyl-CoA Oxidase; AMP-Activated Protein Kinases; Animals; Biomarkers; Caffeine; Carnitine Acyltransf | 2017 |
Extended exposure to sugar and/or caffeine produces distinct behavioral and neurochemical profiles in the orbitofrontal cortex of rats: Implications for neural function.
Topics: Animals; Behavior, Animal; Beverages; Caffeine; Central Nervous System Stimulants; Dietary Carbohydr | 2016 |
Weight gain in older adolescent females: the internet, sleep, coffee, and alcohol.
Topics: Adolescent; Adult; Alcohol Drinking; Body Weight; Caffeine; Coffee; Cohort Studies; Female; Humans; | 2008 |
Weight and plasma lipid control by decaffeinated green tea.
Topics: Adiponectin; Animals; Anti-Obesity Agents; Caffeine; Catechin; Cholesterol; Feces; Hyperlipidemias; | 2009 |
Effects of fluoroquinolones on CYP4501A and 3A in male broilers.
Topics: Animals; Anti-Bacterial Agents; Area Under Curve; Caffeine; Chickens; Ciprofloxacin; Cytochrome P-45 | 2011 |
Body weight gain in rats consuming sweetened liquids. Effects of caffeine and diet composition.
Topics: Animals; Caffeine; Central Nervous System Stimulants; Diet, Fat-Restricted; Dietary Fats; Dietary Su | 2010 |
Intake of cola beverages containing caffeine does not increase, but reduces body weight.
Topics: Caffeine; Dietary Sucrose; Energy Intake; Female; Humans; Male; Obesity; Sucrose; Taste; Weight Gain | 2012 |
Effect of long-term caffeine administration on depressive-like behavior in rats exposed to chronic unpredictable stress.
Topics: Administration, Oral; Animals; Antidepressive Agents, Tricyclic; Behavior, Animal; Body Temperature; | 2012 |
A hypothalamic-pituitary-adrenal axis-associated neuroendocrine metabolic programmed alteration in offspring rats of IUGR induced by prenatal caffeine ingestion.
Topics: Animals; Birth Weight; Blood Glucose; Caffeine; Female; Fetal Growth Retardation; Hippocampus; Hypot | 2012 |
Caffeine prevents weight gain and cognitive impairment caused by a high-fat diet while elevating hippocampal BDNF.
Topics: Analysis of Variance; Animals; Blood Glucose; Brain-Derived Neurotrophic Factor; Caffeine; Central N | 2013 |
Exercise training enhances coronary smooth muscle cell sodium-calcium exchange activity in diabetic dyslipidemic Yucatan swine.
Topics: Animals; Caffeine; Cholesterol, Dietary; Coronary Vessels; Diabetes Mellitus; Dietary Fats; Disease | 2002 |
Post-effects of nandrolone decanoate treatment on contractile responses of rat skeletal muscles.
Topics: Anabolic Agents; Animals; Body Weight; Caffeine; Male; Muscle Contraction; Muscle, Skeletal; Nandrol | 2002 |
Mechanism of the alcohol cyclic pattern: role of catecholamines.
Topics: Alanine Transaminase; Animals; Caffeine; Catecholamines; Drug Synergism; Ephedrine; Ethanol; Liver; | 2003 |
Changes in caffeine intake and long-term weight change in men and women.
Topics: Adult; Age Factors; Body Mass Index; Caffeine; Central Nervous System Stimulants; Coffee; Confidence | 2006 |
Caffeine for apnea of prematurity.
Topics: Apnea; Caffeine; Central Nervous System Stimulants; Diuresis; Growth; Humans; Infant, Low Birth Weig | 2006 |
On the caffeination of prematurity.
Topics: Apnea; Caffeine; Central Nervous System Stimulants; Developmental Disabilities; Humans; Infant, Newb | 2007 |
The effect of caffeine on mammary gland development and milk yield in primiparous sows.
Topics: Aging; Animals; Animals, Suckling; Birth Weight; Caffeine; DNA; Eating; Female; Lactation; Mammary G | 1995 |
The effect of caffeine on food intake in rats: involvement of corticotropin-releasing factor and the sympatho-adrenal system.
Topics: Adrenal Glands; Adrenal Medulla; Animals; Caffeine; Corticotropin-Releasing Hormone; Eating; Epineph | 1994 |
Long-term caffeine treatment leads to a decreased susceptibility to NMDA-induced clonic seizures in mice without changes in adenosine A1 receptor number.
Topics: Animals; Autoradiography; Behavior, Animal; Caffeine; Epilepsy, Tonic-Clonic; Hippocampus; Male; Mic | 1993 |
Nutritional concerns of women with breast cancer.
Topics: Adult; Aged; Attitude to Health; Body Weight; Breast Neoplasms; Caffeine; Diet; Dietary Fats; Female | 1993 |
Prenatal effects of caffeine and restraint stress in mice.
Topics: Abnormalities, Drug-Induced; Animals; Caffeine; Congenital Abnormalities; Eating; Embryonic and Feta | 1999 |
Teas and other beverages suppress D-galactosamine-induced liver injury in rats.
Topics: Alanine Transaminase; Analysis of Variance; Animals; Aspartate Aminotransferases; Beverages; Blood G | 1999 |
Coffee and fitness-coffee suppresses lipopolysaccharide-induced liver injury in rats.
Topics: Alanine Transaminase; Animals; Aspartate Aminotransferases; Caffeine; Cholesterol; Chromatography, H | 2000 |
Interactions in developmental toxicology: combined action of restraint stress, caffeine, and aspirin in pregnant mice.
Topics: Abnormalities, Drug-Induced; Animals; Aspirin; Caffeine; Embryonic and Fetal Development; Female; Ma | 2001 |
Chronic administration of amitriptyline and caffeine in a rat model of neuropathic pain: multiple interactions.
Topics: Amitriptyline; Animals; Antidepressive Agents, Tricyclic; Behavior, Animal; Caffeine; Disease Models | 2001 |
Effects of caffeine and exercise on the development of bone: a densitometric and histomorphometric study in young Wistar rats.
Topics: Animals; Bone and Bones; Bone Density; Bone Development; Caffeine; Calcium; Male; Physical Exertion; | 2002 |